These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 30632609)

  • 1. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.
    Hamada T; Nowak JA; Milner DA; Song M; Ogino S
    J Pathol; 2019 Apr; 247(5):615-628. PubMed ID: 30632609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.
    Ogino S; Nowak JA; Hamada T; Phipps AI; Peters U; Milner DA; Giovannucci EL; Nishihara R; Giannakis M; Garrett WS; Song M
    Gut; 2018 Jun; 67(6):1168-1180. PubMed ID: 29437869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.
    Hamada T; Keum N; Nishihara R; Ogino S
    J Gastroenterol; 2017 Mar; 52(3):265-275. PubMed ID: 27738762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology.
    Ogino S; Nowak JA; Hamada T; Milner DA; Nishihara R
    Annu Rev Pathol; 2019 Jan; 14():83-103. PubMed ID: 30125150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.
    Ogino S; Nishihara R; VanderWeele TJ; Wang M; Nishi A; Lochhead P; Qian ZR; Zhang X; Wu K; Nan H; Yoshida K; Milner DA; Chan AT; Field AE; Camargo CA; Williams MA; Giovannucci EL
    Epidemiology; 2016 Jul; 27(4):602-11. PubMed ID: 26928707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor-immune-microbiome interaction.
    Mima K; Kosumi K; Baba Y; Hamada T; Baba H; Ogino S
    Hum Genet; 2021 May; 140(5):725-746. PubMed ID: 33180176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings of the second international molecular pathological epidemiology (MPE) meeting.
    Ogino S; Campbell PT; Nishihara R; Phipps AI; Beck AH; Sherman ME; Chan AT; Troester MA; Bass AJ; Fitzgerald KC; Irizarry RA; Kelsey KT; Nan H; Peters U; Poole EM; Qian ZR; Tamimi RM; Tchetgen Tchetgen EJ; Tworoger SS; Zhang X; Giovannucci EL; van den Brandt PA; Rosner BA; Wang M; Chatterjee N; Begg CB
    Cancer Causes Control; 2015 Jul; 26(7):959-72. PubMed ID: 25956270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of molecular pathology, epidemiology and social science for global precision medicine.
    Nishi A; Milner DA; Giovannucci EL; Nishihara R; Tan AS; Kawachi I; Ogino S
    Expert Rev Mol Diagn; 2016; 16(1):11-23. PubMed ID: 26636627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.
    Ogino S; Lochhead P; Chan AT; Nishihara R; Cho E; Wolpin BM; Meyerhardt JA; Meissner A; Schernhammer ES; Fuchs CS; Giovannucci E
    Mod Pathol; 2013 Apr; 26(4):465-84. PubMed ID: 23307060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting social MPE: an integration of molecular pathological epidemiology and social science in the new era of precision medicine.
    Dai J; Nishi A; Tran N; Yamamoto Y; Dewey G; Ugai T; Ogino S
    Expert Rev Mol Diagn; 2021 Sep; 21(9):869-886. PubMed ID: 34253130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the microbiome: Emerging biomarkers for exploiting the microbiota for personalized medicine against cancer.
    Rajpoot M; Sharma AK; Sharma A; Gupta GK
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):1-8. PubMed ID: 29425888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings of the third international molecular pathological epidemiology (MPE) meeting.
    Campbell PT; Rebbeck TR; Nishihara R; Beck AH; Begg CB; Bogdanov AA; Cao Y; Coleman HG; Freeman GJ; Heng YJ; Huttenhower C; Irizarry RA; Kip NS; Michor F; Nevo D; Peters U; Phipps AI; Poole EM; Qian ZR; Quackenbush J; Robins H; Rogan PK; Slattery ML; Smith-Warner SA; Song M; VanderWeele TJ; Xia D; Zabor EC; Zhang X; Wang M; Ogino S
    Cancer Causes Control; 2017 Feb; 28(2):167-176. PubMed ID: 28097472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting.
    Campbell PT; Ambrosone CB; Nishihara R; Aerts HJWL; Bondy M; Chatterjee N; Garcia-Closas M; Giannakis M; Golden JA; Heng YJ; Kip NS; Koshiol J; Liu XS; Lopes-Ramos CM; Mucci LA; Nowak JA; Phipps AI; Quackenbush J; Schoen RE; Sholl LM; Tamimi RM; Wang M; Weijenberg MP; Wu CJ; Wu K; Yao S; Yu KH; Zhang X; Rebbeck TR; Ogino S
    Cancer Causes Control; 2019 Aug; 30(8):799-811. PubMed ID: 31069578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathological epidemiology gives clues to paradoxical findings.
    Nishihara R; VanderWeele TJ; Shibuya K; Mittleman MA; Wang M; Field AE; Giovannucci E; Lochhead P; Ogino S
    Eur J Epidemiol; 2015 Oct; 30(10):1129-35. PubMed ID: 26445996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting.
    Yao S; Campbell PT; Ugai T; Gierach G; Abubakar M; Adalsteinsson V; Almeida J; Brennan P; Chanock S; Golub T; Hanash S; Harris C; Hathaway CA; Kelsey K; Landi MT; Mahmood F; Newton C; Quackenbush J; Rodig S; Schultz N; Tearney G; Tworoger SS; Wang M; Zhang X; Garcia-Closas M; Rebbeck TR; Ambrosone CB; Ogino S
    Cancer Causes Control; 2022 Aug; 33(8):1107-1120. PubMed ID: 35759080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression.
    Lochhead P; Chan AT; Nishihara R; Fuchs CS; Beck AH; Giovannucci E; Ogino S
    Mod Pathol; 2015 Jan; 28(1):14-29. PubMed ID: 24925058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncobiome at the Forefront of a Novel Molecular Mechanism to Understand the Microbiome and Cancer.
    Astudillo-de la Vega H; Alonso-Luna O; Ali-Pérez J; López-Camarillo C; Ruiz-Garcia E
    Adv Exp Med Biol; 2019; 1168():147-156. PubMed ID: 31713170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precancer Atlas to Drive Precision Prevention Trials.
    Spira A; Yurgelun MB; Alexandrov L; Rao A; Bejar R; Polyak K; Giannakis M; Shilatifard A; Finn OJ; Dhodapkar M; Kay NE; Braggio E; Vilar E; Mazzilli SA; Rebbeck TR; Garber JE; Velculescu VE; Disis ML; Wallace DC; Lippman SM
    Cancer Res; 2017 Apr; 77(7):1510-1541. PubMed ID: 28373404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science.
    Inamura K; Hamada T; Bullman S; Ugai T; Yachida S; Ogino S
    Gut; 2022 Jul; ():. PubMed ID: 35820782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microbiome and cancer for clinicians.
    Picardo SL; Coburn B; Hansen AR
    Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.